Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamates

References

• Plotniece A, Sobolev A, Supuran CT, Carta F, Björkling F, Franzyk H, Yli-Kauhaluoma J, Augustyns K, Cos P, De Vooght L, et al. Selected strategies to fight pathogenic bacteria. J Enzyme Inhib Med Chem. 2023;38(1):2155816.
   PubMed Web of Science ®Google Scholar
• Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200–216.
   PubMed Web of Science ®Google Scholar
• Castanheira M, Mendes RE, Gales AC. Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus complex. Clin Infect Dis. 2023;76(Suppl 2):S166–S178.
   PubMedGoogle Scholar
• Lepore C, Silver L, Theuretzbacher U, Thomas J, Visi D. The small-molecule antibiotics pipeline: 2014-2018. Nat Rev Drug Discov. 2019;18(10):739–739.
   PubMed Web of Science ®Google Scholar
• Hummels KR, Berry SP, Li Z, Taguchi A, Min JK, Walker S, Marks DS, Bernhardt TG. Coordination of bacterial cell wall and outer membrane biosynthesis. Nature. 2023;615(7951):300–304.
   PubMed Web of Science ®Google Scholar
• Benz F, Hall AR. Host-specific plasmid evolution explains the variable spread of clinical antibiotic-resistance plasmids. Proc Natl Acad Sci U S A. 2023;120(15):e2212147120.
   PubMed Web of Science ®Google Scholar
• Magnano San Lio R, Favara G, Maugeri A, Barchitta M, Agodi A. How antimicrobial resistance is linked to climate change: an overview of two intertwined global challenges. Int J Environ Res Public Health. 2023;20(3):1681.
   PubMedGoogle Scholar
• Devnath P, Karah N, Graham JP, Rose ES, Asaduzzaman M. Evidence of antimicrobial resistance in bats and its planetary health impact for surveillance of zoonotic spillover events: A scoping review. Int J Environ Res Public Health. 2022;20(1):243.
   PubMed Web of Science ®Google Scholar
• Modak JK, Tikhomirova A, Gorrell RJ, Rahman MM, Kotsanas D, Korman TM, Garcia-Bustos J, Kwok T, Ferrero RL, Supuran CT, et al. Anti-Helicobacter pylori activity of ethoxzolamide. J Enzyme Inhib Med Chem. 2019;34(1):1660–1667.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol. 2011;2:34.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat. 2020;30(12):963–982.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci. 2021;135(10):1233–1249.
   PubMed Web of Science ®Google Scholar
• (a) Flaherty DP, Seleem MN, Supuran CT. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem. 2021;13(19):1619–1622.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. An overview of novel antimicrobial carbonic anhydrase inhibitors. Expert Opin Ther Targets. 2023;27(10):897–910.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Capasso C, Supuran CT. Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now? Antibiotics. 2023;12(1):142.
   Google Scholar
• (a) Hewitt CS, Abutaleb NS, Elhassanny AEM, Nocentini A, Cao X, Amos DP, Youse MS, Holly KJ, Marapaka AK, An W, et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis. 2021;7(7):1969–1984.
   PubMed Web of Science ®Google Scholar
  (b) Abutaleb NS, Elhassanny AEM, Nocentini A, Hewitt CS, Elkashif A, Cooper BR, Supuran CT, Seleem MN, Flaherty DP. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J Enzyme Inhib Med Chem. 2022;37(1):51–61.
   PubMed Web of Science ®Google Scholar
  (c) Abutaleb NS, Elhassanny AEM, Seleem MN. In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection. Microb Pathog. 2022;164:105454.
   PubMed Web of Science ®Google Scholar
  d) Abutaleb NS, Elhassanny AE, Flaherty DP, Seleem N. In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. Peer J. 2021;9:e11059.
   PubMed Web of Science ®Google Scholar
• (a) Kaur J, Cao X, Abutaleb NS, Elkashif A, Graboski AL, Krabill AD, AbdelKhalek AH, An W, Bhardwaj A, Seleem MN, et al. Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus. J Med Chem. 2020;63(17):9540–9562.
   PubMed Web of Science ®Google Scholar
  (b) An W, Holly KJ, Nocentini A, Imhoff RD, Hewitt CS, Abutaleb NS, Cao X, Seleem MN, Supuran CT, Flaherty DP. Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases. J Enzyme Inhib Med Chem. 2022;37(1):1838–1844.
   PubMed Web of Science ®Google Scholar
  (c) Abutaleb NS, Shrinidhi A, Bandara AB, Seleem MN, Flaherty DP. Evaluation of 1,3,4-thiadiazole carbonic anhydrase inhibitors for gut decolonization of vancomycin-resistant enterococci. ACS Med Chem Lett. 2023;14(4):487–492.
   PubMed Web of Science ®Google Scholar
• (a) Buzas GM, Birinyi P. Newer, older, and alternative agents for the eradication of Helicobacter pylori infection: a narrative review. Antibiotics. 2023;12(6):946.
   Google Scholar
  (b) Campestre C, De Luca V, Carradori S, Grande R, Carginale V, Scaloni A, Supuran CT, Capasso C. Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori. Front Microbiol. 2021;12:629163.
   PubMed Web of Science ®Google Scholar
  (c) Buzás GM, Supuran CT. The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015). J Enzyme Inhib Med Chem. 2016;31(4):527–533.
   PubMed Web of Science ®Google Scholar
• Fantacuzzi M, D'Agostino I, Carradori S, Liguori F, Carta F, Agamennone M, Angeli A, Sannio F, Docquier JD, Capasso C, et al. Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships. J Enzyme Inhib Med Chem. 2023;38(1):2201402.
   PubMed Web of Science ®Google Scholar
• Giovannuzzi S, Hewitt CS, Nocentini A, Capasso C, Flaherty DP, Supuran CT. Coumarins effectively inhibit bacterial α-carbonic anhydrases. J Enzyme Inhib Med Chem. 2022;37(1):333–338.
   PubMed Web of Science ®Google Scholar
• Giovannuzzi S, Abutaleb NS, Hewitt CS, Carta F, Nocentini A, Seleem MN, Flaherty DP, Supuran CT. Dithiocarbamates effectively inhibit the α-carbonic anhydrase from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem. 2022;37(1):1–8.
   PubMed Web of Science ®Google Scholar
• Giovannuzzi S, Hewitt CS, Nocentini A, Capasso C, Costantino G, Flaherty DP, Supuran CT. Inhibition studies of bacterial α-carbonic anhydrases with phenols. J Enzyme Inhib Med Chem. 2022;37(1):666–671.
   PubMed Web of Science ®Google Scholar
• Vullo D, Durante M, Di Leva FS, Cosconati S, Masini E, Scozzafava A, Novellino E, Supuran CT, Carta F. Monothiocarbamates strongly inhibit carbonic anhydrases in vitro and possess intraocular pressure lowering activity in an animal model of glaucoma. J Med Chem. 2016;59(12):5857–5867.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem. 1971;246(8):2561–2573.
   PubMed Web of Science ®Google Scholar
• Alhashimi M, Mayhoub A, Seleem MN. Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2019;63(12):e01225–e01319.
   PubMed Web of Science ®Google Scholar
• (a) Elkashif A, Seleem MN. Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci Rep. 2020;10(1):5602.
   PubMed Web of Science ®Google Scholar
  (b) Naclerio GA, Abutaleb NS, Alhashimi M, Seleem MN, Sintim HO. N-(1, 3, 4-oxadiazol-2-yl) benzamides as antibacterial agents against Neisseria gonorrhoeae. Int J Mol Sci. 2021;22(5):2427.
   PubMed Web of Science ®Google Scholar
• Seong YJ, Alhashimi M, Mayhoub A, Mohammad H, Seleem MN. Repurposing fenamic acid drugs to combat multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2020;64(7):e02206–e02219.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168–181.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation. Bioorg Med Chem Lett. 2023;93:129411.
   PubMed Web of Science ®Google Scholar